AzurRx BioPharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $26,432,768.
Profit Margin
| 2015 | 0 | -5.93M | |
|---|---|---|---|
| 2016 | 0 | -14.59M | |
| 2017 | 0 | -11.09M | |
| 2018 | 0 | -13.53M | |
| 2019 | 0 | -15.17M | |
| 2020 | 0 | -32.67M |
AZRX Income Statement (2015 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|
Revenue | ||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | ||||||
Research and development | 5.88M | 8.68M | 4.98M | 2.39M | 2.49M | 1.39M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 26.43M | 14.74M | 13.43M | 10.08M | 6.62M | -3.33M |
Operating income | -26.43M | -14.74M | -13.43M | -10.08M | -6.62M | -4.72M |
Other income (expenses), net | -6.23M | -433.93K | -101.84K | -1.01M | -7.96M | -1.20M |
Income before tax | -32.67M | -15.17M | -13.53M | -11.09M | -14.59M | -5.93M |
Income tax expense | -398.08K | 0 | 0 | -140K | -2.02M | 386.10K |
Net income | -32.67M | -15.17M | -13.53M | -11.09M | -14.59M | -5.93M |
Earnings per share | ||||||
Basic EPS | -5.90 | -6.77 | -8.77 | -10.44 | -22.43 | -6.16 |
Diluted EPS | -5.90 | -6.77 | -8.77 | -10.44 | -22.43 | -6.16 |
| Data source | Data source | Data source | Data source | Data source |